Savannah Gabriel

Associate

Overview

Savannah is an associate at Crowell & Moring’s Washington, D.C. office, focusing on both patent litigation and patent prosecution. Savannah was a patent examiner at the U.S. Patent and Trademark Office for six years in a mechanical art unit. She examined a wide range of applications – including respiratory devices, massage devices, exoskeleton devices, and machine learning systems.

Savannah has a background in biomedical engineering. Her coursework included courses in electrical engineering, biology, and organic chemistry.

Career & Education

    • U.S. Patent and Trademark Office
      Examiner, 2019–2025
    • U.S. Patent and Trademark Office
      Examiner, 2019–2025
    • The George Washington University Law School, J.D.
    • The George Washington University, M.Eng., biomedical engineering
    • The George Washington University, B.Sc., biomedical engineering
    • The George Washington University Law School, J.D.
    • The George Washington University, M.Eng., biomedical engineering
    • The George Washington University, B.Sc., biomedical engineering
    • District of Columbia
    • U.S. Patent and Trademark Office (USPTO)
    • District of Columbia
    • U.S. Patent and Trademark Office (USPTO)

Savannah's Insights

Firm News | 2 min read | 05.22.26

Crowell & Moring Represents Kanders & Company in Acquisition of Ginkgo Bioworks’ Biosecurity Business

May 22, 2026: A Crowell & Moring team represented Kanders & Company in a complex carveout transaction in which Kanders acquired the biosecurity business of publicly traded Ginkgo Bioworks. The resulting company, Perimeter Systems, has launched as the world’s first integrated biosecurity infrastructure platform, designed to transform biological signals into real-time intelligence and accelerate decisive response. At closing, Perimeter secured $60 million in growth capital, led by Kanders in partnership with SCS Financial, Goldcrest Capital, Four Cities Capital, and the Safe Artificial Intelligence Fund (SAIF)....

Savannah's Insights

Firm News | 2 min read | 05.22.26

Crowell & Moring Represents Kanders & Company in Acquisition of Ginkgo Bioworks’ Biosecurity Business

May 22, 2026: A Crowell & Moring team represented Kanders & Company in a complex carveout transaction in which Kanders acquired the biosecurity business of publicly traded Ginkgo Bioworks. The resulting company, Perimeter Systems, has launched as the world’s first integrated biosecurity infrastructure platform, designed to transform biological signals into real-time intelligence and accelerate decisive response. At closing, Perimeter secured $60 million in growth capital, led by Kanders in partnership with SCS Financial, Goldcrest Capital, Four Cities Capital, and the Safe Artificial Intelligence Fund (SAIF)....